Emerging Therapies in Hypertrophic Cardiomyopathy: The Potential Role of Cardiac Myosin Inhibition - a podcast by ReachMD

CME credits: 0.25

Valid until: 14-04-2023

Claim your CME credit at https://reachmd.com/programs/cme/emerging-therapies-in-hypertrophic-cardiomyopathy-the-potential-role-of-cardiac-myosin-inhibition/13287/

—Breaking News—Commentary on HCM-related Late-Breaking Abstracts presented at ACC.22 in April has been added to the start of the program. The rest of the program will cover the following topics: Why do we need new therapies in hypertrophic cardiomyopathy (HCM), and will newer and emerging cardiac myosin inhibitors improve the standard of care for patients with HCM? What differences can we expect regarding patient outcomes and quality of life with these new therapies? Join Dr. Ahmad Masri and Dr. Deepak Bhatt as they explore how newer cardiac myosin inhibitors go beyond traditional medical management (that only addresses the macro-pathophysiology and disease symptoms) to actually treat HCM at the cellular level.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD